1) Lucentis
雷珠单抗
1.
Purpose: to evaluate the short-time efficacy of Lucentis associated with PDT and compare that with monotherapy of Lucentis to treat wet age-related macular degeneration.
目的:观察短期单用雷珠单抗和联合光动力疗法治疗湿性年龄相关性黄斑变性的临床疗效比较。
2) Natalizumab
那他珠单抗
1.
The reintroduction of Natalizumab and its risk management plan;
那他珠单抗重返市场给药品风险管理的启示
2.
Progress in treatment of natalizumab on multiple sclerosis;
那他珠单抗治疗多发性硬化研究进展
3.
Risk Monitoring of Biologicals Derived from Adverse Reaction Management of Natalizumab:A Systematic Review Based on Serious Adverse Reaction Reports and Related Regulatory Documents
从那他珠单抗不良反应处理看生物制剂风险监测——基于严重不良反应报告与相关管理文件的系统评价
3) Trastuzumab
曲妥珠单抗
1.
Advances in resistance mechanisms of trastuzumab HER2 monoclonal antibody;
HER2单抗曲妥珠单抗耐药机制研究进展
2.
Results of Two Open-label, Multicenter Phase Ⅱ Studies of Docetaxel, Platinum Salts, and Trastuzumab in HER-2 Positive Advanced Breast Cancer;
多西他赛、铂盐加曲妥珠单抗在HER-2阳性进展期乳腺癌中的两个开放、多中心的Ⅱ期研究结果
3.
Pharmacokinetics, Safety, and Efficacy of Trastuzumab Administered Every Three Weeks in Combination with Paclitaxel for the Treatment of HER-2 Positive Metastatic Breast Carcinoma;
曲妥珠单抗每三周方案联合紫杉醇治疗HER-2阳性转移性乳腺癌的药代动力学、安全性及有效性研究
4) Daclizumab
达利珠单抗
1.
62 case reports of using Daclizumab after renal transplantation;
肾移植术后应用达利珠单抗62例报告
2.
Application of daclizumab to prevent acute rejection after renal transplantation;
达利珠单抗在肾移植术后预防急性排斥反应中的应用
3.
Clinical application of daclizumab for prevention of acute renal allograft rejection;
达利珠单抗在预防同种肾移植急性排斥反应中的临床应用(英文)
5) omalizumab
奥马珠单抗
1.
Treatment with omalizumab for bronchial asthma;
奥马珠单抗对支气管哮喘的治疗作用
6) trastuzumab(Herceptin)
群司珠单抗
补充资料:装箱单、重量单、尺码单
装箱单、重量单、尺码单
[装箱单、皿t单、尺码单1装箱单(Pack-ing Ust)是说明货物包装情况的单据,包括包装材料、包装方式,以及详细的包装内容,如花色、规格搭配等。进口地海关主要依据装箱单对某一特定内容的包装内容进行检查,也是进口商核对货物的依据。装箱单的内容有:单据名称、卖方名称、唆头、件数、规格、数量、毛净重、签字等。 重量单(Weight ust)是由卖方或第三者提供的,表明货物重量的单据。一般包括皮、毛、净重。它必须和其他单据上所表示的货物重量一致。 尺码单就不详细介绍了。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条